BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23626682)

  • 1. Prognostic value of metastatic axillary lymph node ratio for Chinese breast cancer patients.
    Wu SG; He ZY; Li Q; Sun JY; Li FY; Lin Q; Lin HX; Guan XX
    PLoS One; 2013; 8(4):e61410. PubMed ID: 23626682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic axillary lymph node ratio (LNR) is prognostically superior to pN staging in patients with breast cancer--results for 804 Chinese patients from a single institution.
    Xiao XS; Tang HL; Xie XH; Li LS; Kong YN; Wu MQ; Yang L; Gao J; Wei WD; Xie X
    Asian Pac J Cancer Prev; 2013; 14(9):5219-23. PubMed ID: 24175804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the axillary lymph node ratio have any added prognostic value over pN staging for South East Asian breast cancer patients?
    Saxena N; Hartman M; Yip CH; Bhoo-Pathy N; Khin LW; Taib NA; Looi LM; Lim SE; Lee SC; Verkooijen HM
    PLoS One; 2012; 7(9):e45809. PubMed ID: 23029254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of metastatic axillary lymph node ratio in node-positive breast cancer treated by breast conserving surgery].
    Zheng Y; Chen Q; Liang Z; Jia M; Cao X
    Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):41-6. PubMed ID: 25877318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the lymph nodal ratio to predict the risk of locoregional recurrence in lymph node-positive breast cancer patients treated with mastectomy without radiation therapy.
    Wu SG; Chen Y; Sun JY; Li FY; Lin Q; Lin HX; He ZY
    Radiat Oncol; 2013 May; 8():119. PubMed ID: 23672513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node ratio: a new feature for defining risk category of node-positive breast cancer patients.
    Yang C; Liu F; Li S; Li W; Zhai L; Ren M; Li Y; Lang R; Fan Y; Zhang X; Fu L
    Int J Surg Pathol; 2012 Dec; 20(6):546-54. PubMed ID: 22736300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
    Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
    J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node counts and ratio in axillary dissections following neoadjuvant chemotherapy for breast cancer: a better alternative to traditional pN staging.
    Chen S; Liu Y; Huang L; Chen CM; Wu J; Shao ZM
    Ann Surg Oncol; 2014 Jan; 21(1):42-50. PubMed ID: 24013900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of axillary lymph node metastases in invasive lobular breast carcinoma.
    Deberti M; Goupille C; Arbion F; Vilde A; Body G; Ouldamer L
    J Gynecol Obstet Hum Reprod; 2023 Dec; 52(10):102665. PubMed ID: 37734568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer.
    van der Wal BC; Butzelaar RM; van der Meij S; Boermeester MA
    Eur J Surg Oncol; 2002 Aug; 28(5):481-9. PubMed ID: 12217299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node ratio and pN staging show different superiority as prognostic predictors depending on the number of lymph nodes dissected in Chinese patients with luminal A breast cancer.
    Wang F; He W; Qiu H; Wang X; Guo G; Chen X; Rong Y; Zhou F; Yin C; Yuan Z; Xia L
    Clin Breast Cancer; 2012 Dec; 12(6):404-11. PubMed ID: 23026023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional prognostic value of lymph node ratio over pN staging in different breast cancer subtypes based on the results of 1,656 patients.
    Ataseven B; Kümmel S; Weikel W; Heitz F; Holtschmidt J; Lorenz-Salehi F; Kümmel A; Traut A; Blohmer J; Harter P; du Bois A
    Arch Gynecol Obstet; 2015 May; 291(5):1153-66. PubMed ID: 25367604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes.
    Koca E; Kuzan TY; Dizdar O; Babacan T; Sahin I; Ararat E; Altundag K
    Med Oncol; 2013; 30(3):615. PubMed ID: 23729267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional Prognostic Value of Lymph Node Ratio (LNR) and Number of Negative Lymph Nodes (NLNs) in Chinese Patients with Triple Negative Breast Cancer.
    Wang QX; Cai YF; Chen YY; Zhang W; Jin WX; Chen ED; Zhang XH; Li Q
    Ann Clin Lab Sci; 2017 Jan; 47(1):68-75. PubMed ID: 28249920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of lymph node ratio in survival of non-metastatic breast carcinoma patients.
    Singh D; Mandal A
    Breast Cancer Res Treat; 2020 Dec; 184(3):839-848. PubMed ID: 32852709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph Node Ratio in Sentinel Lymph Node Biopsy Era: Are We Losing Prognostic Information?
    Quintyne KI; Woulfe B; Coffey JC; Merrigan A; Gupta RK
    Clin Breast Cancer; 2017 Apr; 17(2):117-126. PubMed ID: 27592541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study.
    Kim SH; Jung KH; Kim TY; Im SA; Choi IS; Chae YS; Baek SK; Kang SY; Park S; Park IH; Lee KS; Choi YJ; Lee S; Sohn JH; Park YH; Im YH; Ahn JH; Kim SB; Kim JH
    Cancer Res Treat; 2016 Oct; 48(4):1373-1381. PubMed ID: 27034147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node ratio is more predictive than traditional lymph node stratification in lymph node positive invasive breast cancer.
    Bai LS; Chen C; Gong YP; Wei W; Tu Y; Yao F; Li JJ; Wang LJ; Sun SR
    Asian Pac J Cancer Prev; 2013; 14(2):753-7. PubMed ID: 23621232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of Ki-67 in breast cancer patients with positive axillary lymph nodes: a retrospective cohort study.
    Li FY; Wu SG; Zhou J; Sun JY; Lin Q; Lin HX; Guan XX; He ZY
    PLoS One; 2014; 9(2):e87264. PubMed ID: 24498305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.